Journal of Enzyme Inhibition and Medicinal Chemistry (Jan 2022)

Novel 3-chloro-6-nitro-1H-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies

  • Mohamed Mokhtar Mohamed Abdelahi,
  • Youness El Bakri,
  • Chin-Hung Lai,
  • Karthikeyan Subramani,
  • El Hassane Anouar,
  • Sajjad Ahmad,
  • Mohammed Benchidmi,
  • Joel T. Mague,
  • Jelena Popović-Djordjević,
  • Souraya Goumri-Said

DOI
https://doi.org/10.1080/14756366.2021.1995380
Journal volume & issue
Vol. 37, no. 1
pp. 151 – 167

Abstract

Read online

An efficient pathway was disclosed for the synthesis of 3-chloro-6-nitro-1H-indazole derivatives by 1,3-dipolar cycloaddition on dipolarophile compounds 2 and 3. Faced the problem of separation of two regioisomers, a click chemistry method has allowed us to obtain regioisomers of triazole-1,4 with good yields from 82 to 90% were employed. Also, the antileishmanial biological potency of the compounds was achieved using an MTT assay that reported compound 13 as a promising growth inhibitor of Leishmania major. Molecular docking demonstrated highly stable binding with the Leishmania trypanothione reductase enzyme and produced a network of hydrophobic and hydrophilic interactions. Molecular dynamics simulations were performed for TryR-13 complex to understand its structural and intermolecular affinity stability in a biological environment. The studied complex remained in good equilibrium with a structure deviation of ∼1–3 Å. MM/GBSA binding free energies illustrated the high stability of TryR-13 complex. The studied compounds are promising leads for structural optimisation to enhance the antileishmanial activity.

Keywords